Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 675 |
|
|||||
| News | - | ||||||
| Tageshoch | 2,18 | Niedrig Hoch |
|||||
| Tagestief | 2,10 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,005 | 0,23% | 2,17 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 2,18 | 2,10 | 2,18 | 2,17 | 2,165 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 58 | 675 | US$ 2,17 | US$ 1.465 | - | 1,62 - 4,05 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:00:00 | 2 | US$ 2,18 | USD |
Finanzwerte ANEB
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 56,28M | 25,93M | - | 0 | -11,73M | -0,45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Anebulo Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 15.5.2024 | 22:31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 15.5.2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.5.2024 | 19:05 | Business Wire | Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year.. |
| 13.2.2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13.2.2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.2.2024 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
| 21.11.2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.11.2023 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
| 30.10.2023 | 14:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 30.10.2023 | 14:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 19.10.2023 | 23:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 06.10.2023 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Anebulo Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ANEB Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,09 | 2,2399 | 2,015 | 2,11 | 1.889 | 0,08 | 3,83% |
| 1 Monat | 3,13 | 3,13 | 2,015 | 2,33 | 5.838 | -0,96 | -30,67% |
| 3 Monate | 2,42 | 3,30 | 2,015 | 2,62 | 5.256 | -0,25 | -10,33% |
| 6 Monate | 2,16 | 3,30 | 1,87 | 2,53 | 7.248 | 0,01 | 0,46% |
| 1 Jahr | 2,74 | 4,05 | 1,62 | 2,50 | 9.787 | -0,57 | -20,80% |
| 3 Jahre | 7,35 | 8,6988 | 1,62 | 3,87 | 8.356 | -5,18 | -70,48% |
| 5 Jahre | 7,38 | 9,33 | 1,62 | 4,58 | 10.287 | -5,21 | -70,60% |
